Biotech
Aug. 11, 2011
John E. Wehrli
Wehrli and two colleagues in Silicon Valley led a Latham & Watkins LLP team that represented South San Francisco-based Alios BioPharma Inc. in a deal with Vertex Pharmaceuticals Inc. that could garner up to $1.5 billion for Alios over the next few years.
The deal, announced in June, was the largest partnership on record for a biotechnology company whose drug hasn't started clinical trials, and it's the industry's largest collaboration...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In